1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPTC Therapeutics considers funding Patient Advocacy grants that fall under specific rare disease areas, including Phenylketonuria (PKU), Duchenne muscular dystrophy (DMD), and Friedreich's ataxia (FA) (US only).
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Organizations with patient advocacy programs in rare disease areas of interest to PTC Therapeutics. Confirm the full requirements in the official notice before applying.
Patient Advocacy Grants is funded by PTC Therapeutics. Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Patient Education Grants is sponsored by Novartis. Novartis provides financial support for educational, advocacy, and outreach activities that improve patient and public health. They accept patient education grant requests from 501(c)(3), 501(c)(4), or 501(c)(6) nonprofit organizations for activities like disease awareness, live events, web-based education, and newsletters in various therapeutic areas, including rare diseases.
Rare As One Network is sponsored by Chan Zuckerberg Initiative. The Chan Zuckerberg Initiative (CZI) is opening a fourth cycle of its Rare As One Network grants, targeting patient-led organizations focused on rare cancers and pulmonary and immune diseases. The program supports patient-led rare disease advocacy organizations to accelerate research within individual disease areas and develop shared research priorities and proposals. Grantees receive funding, training, community learning opportunities, and mentorship.